Published in Mol Endocrinol on June 01, 1992
GATA-binding proteins regulate the human gonadotropin alpha-subunit gene in the placenta and pituitary gland. Mol Cell Biol (1994) 1.37
A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol (1995) 1.23
Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor. Mol Cell Biol (1994) 1.18
Nuclear factor Y and steroidogenic factor 1 physically and functionally interact to contribute to cell-specific expression of the mouse Follicle-stimulating hormone-beta gene. Mol Endocrinol (2003) 1.01
Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone alpha subunit gene by epidermal growth factor and forskolin. Mol Cell Biol (2000) 0.88
A proteomic comparison of immature and mature mouse gonadotrophs reveals novel differentially expressed nuclear proteins that regulate gonadotropin gene transcription and RNA splicing. Biol Reprod (2008) 0.84
Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor. Mol Endocrinol (1997) 0.80
Glucocorticoids induce human glycoprotein hormone alpha-subunit gene expression in the gonadotrope. Endocrinology (2008) 0.80
Corticotropin-releasing hormone receptor expression and functional signaling in murine gonadotrope-like cells. J Endocrinol (2008) 0.76
Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I. J Biol Chem (2010) 0.75
The Colorado thyroid disease prevalence study. Arch Intern Med (2000) 7.84
Creatinine clearance in renal disease. A reappraisal. Br Med J (1969) 3.13
Genomic instability in Gadd45a-deficient mice. Nat Genet (1999) 3.01
Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev (1994) 2.95
Structure of the rat prolactin gene. J Biol Chem (1980) 2.91
Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements. Mol Cell Biol (1987) 2.80
Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science (1988) 2.78
Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev (1988) 2.38
Hemodynamics of uremic anemia. Circulation (1971) 2.29
Genetic analysis in Salmonella typhimurium with a small collection of randomly spaced insertions of transposon Tn10 delta 16 delta 17. J Bacteriol (1987) 2.24
Two enzymes, both of which process recombination intermediates, have opposite effects on adaptive mutation in Escherichia coli. Genetics (1996) 2.14
Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol (1990) 2.05
Acute renal failure after administration of low-molecular weight dextran. N Engl J Med (1967) 1.94
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med (1984) 1.88
Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development (1996) 1.87
Retinoblastoma in transgenic mice. Nature (1990) 1.84
Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes. J Biol Chem (1989) 1.84
Cell-specific transcriptional regulation of follicle-stimulating hormone-beta by activin and gonadotropin-releasing hormone in the LbetaT2 pituitary gonadotrope cell model. Endocrinology (2001) 1.82
Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med (1997) 1.75
Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab (2001) 1.72
Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest (1991) 1.71
Operant conditioning in toilet training of severely mentally retarded boys. Am J Ment Defic (1965) 1.67
Prevalences of symptoms of asthma and other allergic diseases in korean children: a nationwide questionnaire survey. J Korean Med Sci (2001) 1.59
Cell-free synthesis of a large translation product of prolactin messenger RNA. J Biol Chem (1976) 1.57
Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature (1981) 1.56
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Thyroid hormone resistance syndromes. Am J Med (1993) 1.54
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A (1992) 1.46
Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Mol Endocrinol (1996) 1.44
Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab (1995) 1.43
Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid (1994) 1.41
Analysis of 5' flanking sequences and intron-exon boundaries of the rat prolactin gene. J Biol Chem (1981) 1.38
Inhibition of cAMP-dependent protein kinase plays a key role in the induction of mitosis and nuclear envelope breakdown in mammalian cells. EMBO J (1991) 1.38
GATA-binding proteins regulate the human gonadotropin alpha-subunit gene in the placenta and pituitary gland. Mol Cell Biol (1994) 1.37
Construction and analysis of recombinant DNAs containing a structural gene for rat prolactin. Nucleic Acids Res (1979) 1.36
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Partial amino acid sequence of rat pre-prolactin. Biochem J (1977) 1.34
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem (1985) 1.33
Trimethylamine oxide reduction by Salmonella. Can J Microbiol (1974) 1.33
Esophageal varices in adult patients with polycystic kidney and liver disease. N Engl J Med (1973) 1.32
GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Genes Dev (1993) 1.30
MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol Chem (1999) 1.30
Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med (1983) 1.29
A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem (1986) 1.27
Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest (1973) 1.27
The L beta T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. Endocrinology (1996) 1.27
Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol (2006) 1.27
Pit-1 binding sites mediate transcriptional responses to cyclic adenosine 3',5'-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1. Mol Endocrinol (1994) 1.26
Selective binding of the estradiol receptor to a region at least one kilobase upstream from the rat prolactin gene. DNA (1985) 1.25
The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer. Mol Cell Biol (1995) 1.24
Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab (1978) 1.24
A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol (1995) 1.23
A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J Biol Chem (1989) 1.22
Estradiol regulates the transcription of the prolactin gene. J Biol Chem (1982) 1.21
Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol (1994) 1.20
Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. J Clin Invest (1985) 1.20
Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor. Mol Cell Biol (1994) 1.18
Digitalis toxicity and hypomagnesemia. Am Heart J (1970) 1.18
Comparison of potential nuclear precursors for prolactin and growth hormone messenger RNA. J Biol Chem (1980) 1.18
Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. Endocrinology (1991) 1.18
Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. Endocrinology (1991) 1.17
Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation (2001) 1.17
The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol (1994) 1.16
Neuron-specific expression of the rat gonadotropin-releasing hormone gene is conferred by interactions of a defined promoter element with the enhancer in GT1-7 cells. Mol Endocrinol (2000) 1.16
A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP. J Biol Chem (1990) 1.16
GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene. Mol Cell Biol (1996) 1.15
The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab (1976) 1.15
Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol (1992) 1.14
A neuron-specific enhancer targets expression of the gonadotropin-releasing hormone gene to hypothalamic neurosecretory neurons. Mol Endocrinol (1995) 1.13
Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol (1990) 1.13
Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med (1979) 1.13
The Otx2 homeoprotein regulates expression from the gonadotropin-releasing hormone proximal promoter. Mol Endocrinol (2000) 1.12
Estrogen control of prolactin synthesis in vitro. Proc Natl Acad Sci U S A (1978) 1.12
Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab (1975) 1.10
Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res (2001) 1.08
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Functional characterization of cAMP-binding mutations in type I protein kinase. J Biol Chem (1989) 1.08
Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab (1981) 1.08
MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with Pit-1 and GATA-2 on the thyrotropin-beta promoter in thyrotropes. Mol Endocrinol (2006) 1.06
Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. Mol Endocrinol (1991) 1.06
Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab (1977) 1.05
Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev (1993) 1.05
Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab (1976) 1.05
The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. Mol Endocrinol (1992) 1.04
Effect of propranolol on blood pressure and renin in renal hypertension in the rat. Clin Sci Mol Med (1977) 1.04
Nucleotide sequence of the bovine growth hormone chromosomal gene. Mol Cell Endocrinol (1983) 1.04
Complications of surgery in hypothyroid patients. Am J Med (1984) 1.03
Isolation and nucleotide sequence analysis of a cloned cDNA encoding the beta-subunit of bovine follicle-stimulating hormone. DNA (1986) 1.03
Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155). Circulation (1969) 1.02
Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med (1988) 1.01
Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med (1971) 1.00
Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils. J Clin Invest (1985) 1.00
Cell-specific expression of the mouse glycoprotein hormone alpha-subunit gene requires multiple interacting DNA elements in transgenic mice and cultured cells. Mol Endocrinol (1998) 1.00
The thyrotropin beta-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse T alphaT1 cells. Endocrinology (1998) 1.00
Reversible alteration of the visual evoked potential in hypothyroidism. Am J Med (1984) 1.00